POLRMT overexpression increases mtDNA transcription without affecting steady-state mRNA levels
Life Science Alliance · 2025
DOI: 10.26508/lsa.202302563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2025. Verfasst von Maria Miranda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Max Planck Institute for Biology of Ageing, Cologne, Germany. Hauptthemen laut MEDLINE: DNA, Mitochondrial, RNA, Messenger, Transcription, Genetic, DNA-Directed RNA Polymerases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Muscular Dystrophy Association, Agence Nationale de la Recherche, Cancerfonden.
Abstract (Originalsprache)
POLRMT is the sole RNA polymerase in human mitochondria, where it generates primers for mitochondrial DNA (mtDNA) replication and transcribes the mtDNA to express genes encoding essential components of the oxidative phosphorylation (OXPHOS) system. Elevated POLRMT levels are found in several cancers and in mouse models with severe mitochondrial dysfunction. Here, we generated and characterized mice overexpressing Polrmt to investigate the physiological and molecular consequences of elevated POLRMT levels. Increasing POLRMT levels did not result in any pathological phenotype but led to increased exercise performance in male mice under stress conditions. Polrmt overexpression increased mtDNA transcription initiation, resulting in higher steady-state levels of the promoter-proximal L-strand transcript 7S RNA. Surprisingly, the abundance of mature mitochondrial RNAs was not affected by the elevated POLRMT levels. Furthermore, ubiquitous simultaneous overexpression of Polrmt and Lrpprc , which stabilizes mitochondrial messenger RNAs, did not increase steady-state levels of mitochondrial transcripts in the mouse. Our data show that POLRMT levels regulate transcription initiation, but additional regulatory steps downstream of transcription initiation and transcript stability limit OXPHOS biogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Max Planck Institute for Biology of Ageing, Cologne, Germany.
- Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell, Gif-sur-Yvette, France.
- The Kids Research Institute Australia, Northern Entrance, Perth Children's Hospital, Nedlands, Australia.
- ARC Centre of Excellence in Synthetic Biology, University of Western Australia, Crawley, Australia.
- Université de Bordeaux, CNRS, IBGC, UMR 5095, Bordeaux, France.
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Maria Miranda, Ilian Atanassov, Arnaud Mourier, Nils-Göran Larsson, Inge Kühl
Förderung
- French Muscular Dystrophy Association
- Agence Nationale de la Recherche
- Cancerfonden
- Vetenskapsrådet
- Knut och Alice Wallenbergs Stiftelse
- EC | European Research Council
- Novo Nordisk Fonden
- Fondation ARC pour la Recherche sur le Cancer
Zitieren
APA
Miranda, M., Mesaros, A., Scrima, N., Pérard, L., Kuznetsova, I., Purrio, M., Atanassov, I., Filipovska, A., Mourier, A., Larsson, N. G., & Kühl, I. (2025). POLRMT overexpression increases mtDNA transcription without affecting steady-state mRNA levels. Life Science Alliance. https://doi.org/10.26508/lsa.202302563
Vancouver
Miranda M, Mesaros A, Scrima N, Pérard L, Kuznetsova I, Purrio M, et al. POLRMT overexpression increases mtDNA transcription without affecting steady-state mRNA levels. Life Science Alliance. 2025. doi:10.26508/lsa.202302563
BibTeX
@article{Miranda2025,
author = {Miranda, Maria and Mesaros, Andrea and Scrima, Nathalie and Pérard, Louise and Kuznetsova, Irina and Purrio, Martin and Atanassov, Ilian and Filipovska, Aleksandra and Mourier, Arnaud and Larsson, Nils-Göran and Kühl, Inge},
title = {POLRMT overexpression increases mtDNA transcription without affecting steady-state mRNA levels},
journal = {Life Science Alliance},
year = {2025},
doi = {10.26508/lsa.202302563}
}
EUVIMED